000 01171 a2200337 4500
005 20250516172506.0
264 0 _c20140626
008 201406s 0 0 eng d
022 _a1872-6844
024 7 _a10.1016/j.eplepsyres.2013.08.016
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aBelcastro, Vincenzo
245 0 0 _aMetabolic and endocrine effects of valproic acid chronic treatment.
_h[electronic resource]
260 _bEpilepsy research
_cNov 2013
300 _a1-8 p.
_bdigital
500 _aPublication Type: Journal Article; Review
650 0 4 _aAnticonvulsants
_xadverse effects
650 0 4 _aEpilepsy
_xblood
650 0 4 _aHumans
650 0 4 _aHyperinsulinism
_xchemically induced
650 0 4 _aInsulin Resistance
650 0 4 _aLeptin
_xblood
650 0 4 _aMetabolic Syndrome
_xblood
650 0 4 _aValproic Acid
_xadverse effects
650 0 4 _aWeight Gain
_xdrug effects
700 1 _aD'Egidio, Claudia
700 1 _aStriano, Pasquale
700 1 _aVerrotti, Alberto
773 0 _tEpilepsy research
_gvol. 107
_gno. 1-2
_gp. 1-8
856 4 0 _uhttps://doi.org/10.1016/j.eplepsyres.2013.08.016
_zAvailable from publisher's website
999 _c23126073
_d23126073